Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Seminars in Arthritis and Rheumatism|May 23, 2025
Nervous system involvement in ANCA-associated vasculitis: Single center experience from Latin AmericaLina Paola Quintero-Giraldo, Julian Barahona-Correa, David Corredor-Orlandelli, et al.
Journal of Back and Musculoskeletal Rehabilitation|March 1, 2019
Factors associated with non-specific low back pain in children aged 10-12 from Bucaramanga, Colombia: A cross-sectional studyAdriana Angarita-Fonseca, Milena Boneth-Collante, Claudia Lucia Ariza-Garcia, et al.
Cureus|February 20, 2025
Impact of SGLT2 Inhibitors on Preventing Heart Failure Hospitalizations in Colombian Patients With Uncontrolled Type 2 Diabetes MellitusDavid Alexander Vernaza Trujillo, Lendy Yaneth Rojas Bautista, Claudia Marcela Ramirez Espinosa, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 23, 2024
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the ArtDavid Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera-Martínez, et al.
Nature Communications|September 9, 2024
Identification of an embryonic differentiation stage marked by Sox1 and FoxA2 co-expression using combined cell tracking and high dimensional protein imagingGeethika Arekatla, Stavroula Skylaki, David Corredor Suarez, et al.
Cureus|January 13, 2025
Biochemical Control in a Colombian Cohort of Patients With Acromegaly: A 12-Month Follow-Up Study (2017-2023)Alin Abreu Lomba, David Corredor-Rengifo, Cesar Augusto Mejia Velez, et al.
Frontiers in Endocrinology|July 22, 2025
A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists - a comprehensive reviewDavid Aristizábal-Colorado, David Corredor-Rengifo, Santiago Sierra-Castillo, et al.
Frontiers in Endocrinology|September 5, 2025
Correction: A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists - a comprehensive reviewDavid Aristizábal-Colorado, David Corredor-Rengifo, Santiago Sierra-Castillo, et al.
Frontiers in Medicine|July 7, 2022
Association Between the LZTFL1 rs11385942 Polymorphism and COVID-19 Severity in Colombian PopulationMariana Angulo-Aguado, David Corredor-Orlandelli, Juan Camilo Carrillo-Martínez, et al.
Vascular Health and Risk Management|November 12, 2021
Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian PopulationDavid Corredor-Orlandelli, Santiago Sambracos-Parrado, Santiago Mantilla-García, et al.
Pageof 2